Cite
HARVARD Citation
Thill, M. et al. (n.d.). The REMAR (Rhein-Main-Registry)-Study: Prospective evaluation of oncotype DX® Assay in Addition to Ki-67 for adjuvant treatment decisions in early breast cancer. European journal of cancer. pp. S92-S93. [Online].